Please select a community
Automation & Microfluidics
Biologics & Bioprocessing
Chemical Process Scale Up
Food & Beverage Analysis
Forensic Science & Clinical Toxicology
Genotyping & Gene Expression
LIMS & ELNs
Metabolomics & Lipidomics
Molecular & Clinical Diagnostics
Next Gen Sequencing
Stem Cells, Cellular Therapy & Biobanking
Become a Member
Add My Products
Production Line Clean Air Solution Launches to Pharma Industry Interest
Friday, October 17, 2014
A unique new product, set to minimise the costs associated with manufacturing drug packaging to GMP standards, has received great interest since its launch at a UK trade event.
Era7 Launches its New Service Genome7
Wednesday, October 15, 2014
An integrated solution for Cancer Genomics.
3D Triculture Model for Evaluating Breast Cancer Progression
Wednesday, October 01, 2014
New application note introduces a more predictive and realistic model for drug screening of cancer therapeutics.
Easy and Cost-Effective Generation of siRNAs from Full-Length Target Genes
Wednesday, September 24, 2014
Dicer siRNA generation kit from AMSBIO.
Biocartis Launches Its Flagship Molecular Diagnostics Platform Idylla™
Friday, September 12, 2014
Idylla™’s first test identifies cancers driven by the BRAF oncogene. Cancer patients will benefit significantly from faster therapy decisions and better guidance of treatment choices.
Meet SeedEZ, a universal 3D cell culture drug screening system
Sunday, September 07, 2014
Lena Biosciences introduces a robust and easy to use SeedEZ 3D cell culture drug screening system supporting consistent yet complex 3D cell culture, co-culture and multilayered tissue models with immune and inflammatory components.
Easy-to-use, Quantitative Gamma-H2AX Assay
Tuesday, September 02, 2014
Gamma H2AX pharmacodynamic assay kit for the study of double strand DNA breaks.
Versatile Range of Horizontal Gel Electrophoresis Units
Tuesday, September 02, 2014
Cleaver MultiSUB™ gel electrophoresis range for low- and high-throughput DNA and RNA applications.
Onxeo Strengthens Beleodaq® Patent Protection in the U.S. Until 2027
Friday, August 29, 2014
U.S. Patent will be granted on September 16th 2014.
Showing Results 51 - 60 of 705
RNAi Screening Trends
Understand current trends and learn which application areas are expected to gain in popularity over the next few years.
A Gene-Sequence Swap Using CRISPR to Cure Haemophilia
For the first time chromosomal defects responsible for hemophilia have been corrected in patient-specific iPSCs using CRISPR-Cas9 nucleases
New Tool Uses 'Drug Spillover' to Match Cancer Patients with Treatments
Researchers have developed a new tool that improves the ability to match drugs to disease: the Kinase Addiction Ranker (KAR) predicts what genetics are truly driving the cancer in any population of cells and chooses the best "kinase inhibitor" to silence these dangerous genetic causes of disease.
New Material Opens Possibilities for Super-Long-Acting Pills
A pH-responsive polymer gel could create swallow able devices, including capsules for ultra-long drug delivery.
New Tool For Investigating RNA Gone Awry
A new technology – called “Sticky-flares” – developed by nanomedicine experts at Northwestern University offers the first real-time method to track and observe the dynamics of RNA distribution as it is transported inside living cells.
Access Denied: Leukemia Thwarted by Cutting Off Link to Environmental Support
A new study reveals a protein’s critical – and previously unknown -- role in the development and progression of acute myeloid leukemia (AML), a fast-growing and extremely difficult-to-treat blood cancer.
New Weapon in the Fight Against Blood Cancer
This strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
TOPLESS Plants Provide Clues to Human Molecular Interactions
Scientists at Van Andel Research Institute have revealed an important molecular mechanism in plants that has significant similarities to certain signaling mechanisms in humans, which are closely linked to early embryonic development and to diseases such as cancer.
Toxin from Salmonid Fish has Potential to Treat Cancer
Researchers from the University of Freiburg decode molecular mechanism of fish pathogen.
Scientists Create CRISPR/Cas9 Knock-In Mutations in Human T Cells
In a project spearheaded by investigators at UC San Francisco, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.
Advertise On This Site
Terms & Conditions
©2015 Technology Networks
, all rights reserved.
Latest presentations and webinars
2,400+ scientific and medical posters
3,700+ scientific videos
JOIN TECHNOLOGY NETWORKS PREMIUM FREE!